Sign inCreate account

Report workspace tools

NCT04888377COMPLETEDanonymous

Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial

Sponsor

Source record

NICHD Global Network for Women's and Children's Health

Phase

Source record

Completed

Modality

AI-normalized

small molecule

Target

AI-normalized

Neurodevelopmental Abnormality

Indication / condition

AI-normalized

Neurodevelopmental Abnormality

Intervention

Source record

Aspirin, Placebo

Source & freshness

Source record

NCT ID

NCT04888377

Original source

ClinicalTrials.gov

Source last updated

Oct 21, 2024

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04888377

Title

Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial

Sponsor

NICHD Global Network for Women's and Children's Health

Status

COMPLETED

Phase

Completed

Condition raw

Neurodevelopmental Abnormality

Condition normalized

Neurodevelopmental Abnormality

Modality raw

Neurodevelopmental Abnormality

Modality normalized

small molecule

Target raw

Neurodevelopmental Abnormality

Target normalized

Neurodevelopmental Abnormality

Interventions

Aspirin, Placebo

Public preview

Source record

The ASPIRIN Neurodevelopmental Follow-up Trial aimed to assess the impact of antenatal low-dose aspirin on the neurodevelopment of children whose mothers participated in the original ASPIRIN trial. The study enrolled 620 children across multiple sites in low- and middle-income countries, focusing on cognitive, language, and motor development outcomes at 36 months of age.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04888377

Status

COMPLETED

Phase

Completed

Sponsor

NICHD Global Network for Women's and Children's Health

Executive brief

Investment-Ready Snapshot

The ASPIRIN Neurodevelopmental Follow-up Trial aimed to assess the impact of antenatal low-dose aspirin on the neurodevelopment of children whose mothers participated in the original ASPIRIN trial. The study enrolled 620 children across multiple sites in low- and middle-income countries, focusing on cognitive, language, and motor development outcomes at 36 months of age.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedOct 21, 2024
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04888377

Indication

Neurodevelopmental Abnormality

Modality

small molecule

Target

Neurodevelopmental Abnormality

Intervention

Aspirin, Placebo

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.